Advanced H&I – Solid Organ Transplantation and Transfusion —
Training activity: 10

Details

Select a sensitised patient and prepare an interpretive report for cardiothoracic transplant with a deceased donor offer

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

• National guidelines and reporting in-line with current accreditation standards
• Clinical interpretation
• Using all results and patient history

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

• What is the purpose of selecting a sensitised patient and preparing this interpretive report?
• How will this report inform the transplant team’s decision-making regarding the suitability of the donor offer?
• What is your understanding of HLA sensitisation and its implications for cardiothoracic transplantation?
• Are you familiar with the specific considerations and urgency involved in these types of transplants?
• What key information needs to be included in an interpretive report for a sensitised patient in this context?
• What specific skills in assessing the immunological risk for a sensitised patient receiving a cardiothoracic transplant offer do you hope to develop?
• How will you learn to prioritise critical information and present it clearly and concisely to clinical colleagues?
• What are the specific challenges associated with interpreting data in this urgent setting that you want to understand better? How do you anticipate the time pressure influencing your approach?
• What patient data will you need to review (e.g., comprehensive HLA antibody history, virtual crossmatch results)?
• Will you familiarise yourself with relevant national guidelines for risk assessment in cardiothoracic transplantation?
• Will you discuss the case and the structure of the report with your supervisor beforehand? How do you feel about the high-stakes nature of this activity?

In action

• What key aspects of the sensitised patient’s history and serological profile are you currently reviewing? What specific HLA antibodies are present and what are their strengths or specificities?
• How are you comparing the patient’s antibody profile with the HLA typing of the deceased donor offer? What calculations or risk assessments are you performing to evaluate the compatibility?
• How are you structuring your interpretive report to clearly communicate the compatibility assessment and any potential risks?
• Are you finding the available data on the patient and donor sufficient and clear? How effective are you at identifying unacceptable antigens and potential for antibody-mediated rejection?
• What challenges are you encountering in interpreting the significance of specific antibody levels or specificities in the context of cardiothoracic transplantation? W
• hat are you learning about the unique immunological considerations for cardiothoracic transplantation in sensitised patients?
• If there are antibodies present that may or may not be clinically significant, how are you addressing this uncertainty in your interpretation?
• Are you considering the need for a virtual or physical crossmatch?
• What level of detail are you including in your report to provide appropriate clinical advice?
• Are you ensuring your assessment aligns with national guidelines for immunological risk assessment in cardiothoracic transplantation?

On action

• What were the key aspects of the patient’s sensitisation history that you needed to consider?
  • How did you use this information to assess the suitability of the deceased donor offer?
  • What specific tests or analyses were crucial in this assessment?
  • What information did you include in your interpretive report for the clinical team?
• How does prior sensitisation impact the risk of rejection in cardiothoracic transplantation?
  • What are the key elements of an immunological risk assessment for cardiothoracic donation?
  • How do you integrate HLA typing, antibody screening, and virtual crossmatch data in this context?
  • What is the importance of timely and accurate reporting in deceased donor transplantation?
• How will you approach the assessment of deceased donor offers for sensitised cardiothoracic transplant candidates in the future?
  • What further knowledge do you need about specific antibodies and their clinical significance in this setting?
  • How will you ensure your reports provide the necessary information for informed clinical decision-making?

Beyond action

• Have you reviewed the case of the sensitised patient and the interpretive report you prepared for the cardiothoracic transplant deceased donor offer?
• Have you re-evaluated your assessment of the patient’s sensitisation profile and the compatibility with the donor based on any subsequent learning or guideline updates?
• Did feedback from your supervisor or the clinical team provide further understanding of the factors considered in such cases?
• Has this training activity enhanced your understanding of the specific immunological considerations for cardiothoracic transplantation in sensitised patients?
• How has this experience influenced your ability to synthesise complex data (HLA typing, antibody screening, virtual crossmatch) into a concise and clinically relevant interpretive report? Has it improved your confidence in providing interpretive reports for complex transplant scenarios?
• How has this activity contributed to your ability to interpret and report tests across the range of techniques applied and provide appropriate clinical advice for solid organ transplant?
• Will the skills developed in this training activity be applicable to other complex transplant cases or in discussions within a multidisciplinary team?
• What further learning or experience in the area of highly sensitised transplant recipients would you like to pursue?

Relevant learning outcomes

#	Outcome
# 2	Outcome Interpret and report tests across the range of techniques applied and provide appropriate clinical advice for solid organ transplant.
# 3	Outcome Assess the suitability of patients for crossmatch and transplantation in deceased and live donor settings.
# 7	Outcome Practice in accordance with quality management and accreditation standards.
# 8	Outcome Practice effectively in partnership with service users, other clinical specialisms and the wider multidisciplinary team in the investigation of solid organ transplantation and platelet transfusion.